Potential link between aluminum salts in deodorants and breast cancer warrants further research

February 28, 2006

Chemicals that mimic the body's natural hormone oestrogen are known to affect a woman's risk of breast cancer. Evidence is mounting that the aluminium-based compound, which often makes up quarter of the volume of some antiperspirant agents, can break through the skin and that once in the body it could mimic oestrogen. A review just published in the Journal of Applied Toxicology calls for further research to evaluate the potential that this could increase the risk of getting breast cancer.

Over recent years scientists have found that many compounds in the environment mimic or interfere with oestrogen. These compounds are normally complex molecules and are found in many plants, and used in materials like detergents, pesticides and plastics. Now scientists are realising that a variety of simple metal ions, including aluminium and cadmium can also bind to the body's oestrogen-receptors and influence their action.

"Since oestrogen is known to be involved in the development and progression of human breast cancer, any components of the environment that have oestrogenic activity and which can enter the human breast could theoretically influence a woman's risk of breast cancer," says author of the review Dr Philippa Darbre, who works in the School of Biological Sciences, at the University of Reading, UK.

Aluminium salts in antiperspirants are a major source of exposure to aluminium in humans. It is often sprayed into armpits, inadvertently concentrating exposure near to the breast. In addition, it is often applied immediately after shaving, when the skin is likely to be damaged and less able to keep the aluminium out. "It is reasonable to question whether this aluminium could then influence breast cancer," says Darbre.

Her concern is not confined to aluminium. Smoking tobacco introduces cadmium into the body, and research shows that it too can collect in breast tissue. There are indications that this accumulation of cadmium may also be linked to an increased risk of breast cancer, potentially showing one of the reasons why smoking could be linked to this disease.

"Each of these agents on their own may not have a powerful effect, but we need to see what happens when a number of them act together - it could be that this would have a significant effect on diseases like breast cancer," says Darbre.
-end-
Article: Darbre P D. Metalloestrogens: An Emerging Class of Inorganic Xenoestrogens with Potential to Add to the Oestrogenic Burden of the Human Breast. Journal of Applied Toxicology 2006; DOI:10.1002/jat.1135

The Journal of Applied Toxicology is devoted to publishing original research, theoretical and literature reviews relating to the toxicity of drugs and chemicals to living systems at the molecular, cellular, tissue and target organ level. This also encompasses teratogenesis, carcinogenesis, mutagenesis, mechanistic toxicology, pharmacokinetics, environmental toxicology and environmental health (including epidemiological studies) in addition to analytical and method development studies. Papers dealing with in vitro techniques and alternatives to the use of animals are encouraged. The journal's Editor-in-Chief is Dr Harry Salem of the Edgewood Chemical & Biological Center, USA, and Dr Philip Harvey of Covance Laboratories UK Ltd, Harrogate is its European Editor. The journal can be accessed online via Wiley Interscience at http://www.interscience.wiley.com/journal/jat.

About John Wiley & Sons, Inc.

Founded in 1807, John Wiley & Sons, Inc., provides must-have content and services to customers worldwide. Our core businesses include scientific, technical, and medical journals, encyclopedias, books, and online products and services; professional and consumer books and subscription services; and educational materials for undergraduate and graduate students and lifelong learners. Wiley has publishing, marketing, and distribution centers in the United States, Canada, Europe, Asia, and Australia. The company is listed on the New York Stock Exchange under the symbols JWa and JWb. Wiley's Internet site can be accessed at http://www.wiley.com.

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.